Hvilken er prisen på Handa Pharmaceuticals, Inc. (6620)

Prisen på Handa Pharmaceuticals, Inc. (6620) er $2.95

Hva er markedsverdien på Handa Pharmaceuticals, Inc. (6620)

Markedsverdien på Handa Pharmaceuticals, Inc. (6620) er $491.95M

Handa Pharmaceuticals, Inc. (6620) Aksjesplitter

Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.

År	Splitt	Multiplikator	Kumulativ multiplikator
Ikke nok data for de angitte datoene.

År

Splitt

Multiplikator

Kumulativ multiplikator

Ikke nok data for de angitte datoene.

Selskap	Antall aksjesplitt	Kumulativ multiplikator	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN
Galderma Group AG GALD.SW	0	-	CH

Selskap

Antall aksjesplitt

Kumulativ multiplikator

Land